Target Regulator(s) Information (Transcription Factor)
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T17758 | Target Info | |||
Target Name | Urokinase-type plasminogen activator (PLAU) | ||||
Synonyms | UPA; U-plasminogen activator | ||||
Target Type | Successful Target | ||||
Gene Name | PLAU | ||||
Biochemical Class | Peptidase | ||||
UniProt ID |
The Transcription Factors (TFs) Regulating This Target | Top | ||||
---|---|---|---|---|---|
TF Name | c-Jun/c-Fos (AP-1) heterodimer | ||||
Classification | Superclass | Basic Domains | |||
Class | Leucine zipper factors (bZIP) | ||||
Family | AP-1(-like) components | ||||
Regulation Mechanism | The uPA (also referred as PLAU) enhancer regulation involves the increased expression and phosphorylation of multiple AP-1 components such as c-Jun, JunD, and ATF-2, along with the IL-1- and TPA-dependent activation of the ets family member Ets-2. | [1] | |||
Evidence Score (E-score) | 3 | + | |||
1 | DNase I Footprint Analysis | [1] | |||
2 | DNase I Footprint Analysis | [3] | |||
3 | Reporter Assay | [4] | |||
UniProt ID | |||||
Sequence |
MTAKMETTFYDDALNASFLPSESGPYGYSNPKILKQSMTLNLADPVGSLKPHLRAKNSDL
LTSPDVGLLKLASPELERLIIQSSNGHITTTPTPTQFLCPKNVTDEQEGFAEGFVRALAE LHSQNTLPSVTSAAQPVNGAGMVAPAVASVAGGSGSGGFSASLHSEPPVYANLSNFNPGA LSSGGGAPSYGAAGLAFPAQPQQQQQPPHHLPQQMPVQHPRLQALKEEPQTVPEMPGETP PLSPIDMESQERIKAERKRMRNRIAASKCRKRKLERIARLEEKVKTLKAQNSELASTANM LREQVAQLKQKVMNHVNSGCQLMLTQQLQTF |
||||
The Genes (Co-regulated by This TF) Grouped Based on Their Biochemical Classes | |||||
Acyltransferases | [+] 1 Acyltransferases Co-regulated By This TF | + | |||
1 | Glutathione S-transferase P (GSTP1) | Clinical trial Target | Target Info | [6] | |
Cytokines / Cytokine receptors | [+] 1 Cytokines / Cytokine receptors Co-regulated By This TF | + | |||
1 | Interferon-gamma (IFNG) | Successful Target | Target Info | [7] | |
Endothelins/sarafotoxins | [+] 1 Endothelins/sarafotoxins Co-regulated By This TF | + | |||
1 | Endothelin-1 (EDN1) | Literature-reported Target | Target Info | [8] | |
G protein-coupled receptors | [+] 1 G protein-coupled receptors Co-regulated By This TF | + | |||
1 | Gonadotropin-releasing hormone receptor (GNRHR) | Successful Target | Target Info | [9] | |
Glucagons | [+] 1 Glucagons Co-regulated By This TF | + | |||
1 | Vasoactive intestinal polypeptide (VIP) | Literature-reported Target | Target Info | [10] | |
Hormones | [+] 1 Hormones Co-regulated By This TF | + | |||
1 | Corticoliberin (CRH) | Literature-reported Target | Target Info | [11] | |
Integrins | [+] 1 Integrins Co-regulated By This TF | + | |||
1 | Integrin alpha-2 (ITGA2) | Clinical trial Target | Target Info | [12] | |
Oxidoreductases | [+] 1 Oxidoreductases Co-regulated By This TF | + | |||
1 | Quinone reductase 1 (NQO1) | Clinical trial Target | Target Info | [13] | |
Peptidases | [+] 1 Peptidases Co-regulated By This TF | + | |||
1 | Urokinase-type plasminogen activator (PLAU) | Successful Target | Target Info | [1] | |
Somatotropin / Prolactins | [+] 1 Somatotropin / Prolactins Co-regulated By This TF | + | |||
1 | Prolactin (PRL) | Discontinued Target | Target Info | [14] | |
Transcription factors | [+] 2 Transcription factors Co-regulated By This TF | + | |||
1 | Cellular tumor antigen p53 (TP53) | Clinical trial Target | Target Info | [15] | |
2 | Transcription factor AP-1 (JUN) | Discontinued Target | Target Info | [16] | |
TF Name | JunD proto-oncogene (Jun-D) homodimer | ||||
Classification | Superclass | Basic Domains | |||
Class | Leucine zipper factors (bZIP) | ||||
Family | AP-1(-like) components | ||||
Subfamily | Jun | ||||
Regulation Mechanism | The PLAU enhancer regulation involves the increased expression and phosphorylation of multiple AP-1 components such as c-Jun, Jun-D, and ATF-2, along with the IL-1- and TPA-dependent activation of the ets family member Ets-2. | [1] | |||
Evidence Score (E-score) | 2 | + | |||
1 | DNase I Footprint Analysis | [1] | |||
2 | Electrophoretic Mobility Shift Assay | [5] | |||
UniProt ID | |||||
Sequence |
METPFYGDEALSGLGGGASGSGGSFASPGRLFPGAPPTAAAGSMMKKDALTLSLSEQVAA
ALKPAAAPPPTPLRADGAPSAAPPDGLLASPDLGLLKLASPELERLIIQSNGLVTTTPTS SQFLYPKVAASEEQEFAEGFVKALEDLHKQNQLGAGAAAAAAAAAAGGPSGTATGSAPPG ELAPAAAAPEAPVYANLSSYAGGAGGAGGAATVAFAAEPVPFPPPPPPGALGPPRLAALK DEPQTVPDVPSFGESPPLSPIDMDTQERIKAERKRLRNRIAASKCRKRKLERISRLEEKV KTLKSQNTELASTASLLREQVAQLKQKVLSHVNSGCQLLPQHQVPAY |
||||
The Genes (Co-regulated by This TF) Grouped Based on Their Biochemical Classes | |||||
Peptidases | [+] 1 Peptidases Co-regulated By This TF | + | |||
1 | Urokinase-type plasminogen activator (PLAU) | Successful Target | Target Info | [1] | |
TF Name | cAMP-dependent transcription factor 2 (ATF-2) homodimer | ||||
Classification | Superclass | Basic Domains | |||
Class | Leucine zipper factors (bZIP) | ||||
Family | AP-1(-like) components | ||||
Subfamily | CRE-BP/ATF | ||||
Regulation Mechanism | The uPA (also referred as PLAU) enhancer regulation involves the increased expression and phosphorylation of multiple AP-1 components such as c-Jun, JunD, and ATF-2, along with the IL-1- and TPA-dependent activation of the ets family member Ets-2. | [1] | |||
Evidence Score (E-score) | 1 | + | |||
1 | DNase I Footprint Analysis | [1] | |||
UniProt ID | |||||
Sequence |
MKFKLHVNSARQYKDLWNMSDDKPFLCTAPGCGQRFTNEDHLAVHKHKHEMTLKFGPARN
DSVIVADQTPTPTRFLKNCEEVGLFNELASPFENEFKKASEDDIKKMPLDLSPLATPIIR SKIEEPSVVETTHQDSPLPHPESTTSDEKEVPLAQTAQPTSAIVRPASLQVPNVLLTSSD SSVIIQQAVPSPTSSTVITQAPSSNRPIVPVPGPFPLLLHLPNGQTMPVAIPASITSSNV HVPAAVPLVRPVTMVPSVPGIPGPSSPQPVQSEAKMRLKAALTQQHPPVTNGDTVKGHGS GLVRTQSEESRPQSLQQPATSTTETPASPAHTTPQTQSTSGRRRRAANEDPDEKRRKFLE RNRAAASRCRQKRKVWVQSLEKKAEDLSSLNGQLQSEVTLLRNEVAQLKQLLLAHKDCPV TAMQKKSGYHTADKDDSSEDISVPSSPHTEAIQHSSVSTSNGVSSTSKAEAVATSVLTQM ADQSTEPALSQIVMAPSSQSQPSGS |
||||
The Genes (Co-regulated by This TF) Grouped Based on Their Biochemical Classes | |||||
Apoptosis regulators | [+] 1 Apoptosis regulators Co-regulated By This TF | + | |||
1 | Apoptosis regulator Bcl-2 (BCL-2) | Successful Target | Target Info | [17] | |
Cytokines / Cytokine receptors | [+] 1 Cytokines / Cytokine receptors Co-regulated By This TF | + | |||
1 | Interferon-gamma (IFNG) | Successful Target | Target Info | [18] | |
Growth factors | [+] 1 Growth factors Co-regulated By This TF | + | |||
1 | Transforming growth factor beta 2 (TGFB2) | Clinical trial Target | Target Info | [19] | |
Peptidases | [+] 2 Peptidases Co-regulated By This TF | + | |||
1 | Tissue-type plasminogen activator (PLAT) | Successful Target | Target Info | [20] | |
2 | Urokinase-type plasminogen activator (PLAU) | Successful Target | Target Info | [1] | |
TF Name | c-Jun/ATF-2 (AP-1) heterodimer | ||||
Classification | Superclass | Basic Domains | |||
Class | Leucine zipper factors (bZIP) | ||||
Family | AP-1(-like) components | ||||
Subfamily | Jun | ||||
Regulation Mechanism | The uPA (also referred as PLAU) enhancer regulation involves the increased expression and phosphorylation of multiple AP-1 components such as c-Jun, JunD, and ATF-2, along with the IL-1- and TPA-dependent activation of the ets family member Ets-2. | [1] | |||
Evidence Score (E-score) | 1 | + | |||
1 | DNase I Footprint Analysis | [1] | |||
UniProt ID | |||||
Sequence |
MTAKMETTFYDDALNASFLPSESGPYGYSNPKILKQSMTLNLADPVGSLKPHLRAKNSDL
LTSPDVGLLKLASPELERLIIQSSNGHITTTPTPTQFLCPKNVTDEQEGFAEGFVRALAE LHSQNTLPSVTSAAQPVNGAGMVAPAVASVAGGSGSGGFSASLHSEPPVYANLSNFNPGA LSSGGGAPSYGAAGLAFPAQPQQQQQPPHHLPQQMPVQHPRLQALKEEPQTVPEMPGETP PLSPIDMESQERIKAERKRMRNRIAASKCRKRKLERIARLEEKVKTLKAQNSELASTANM LREQVAQLKQKVMNHVNSGCQLMLTQQLQTF |
||||
The Genes (Co-regulated by This TF) Grouped Based on Their Biochemical Classes | |||||
Peptidases | [+] 1 Peptidases Co-regulated By This TF | + | |||
1 | Urokinase-type plasminogen activator (PLAU) | Successful Target | Target Info | [1] | |
TF Name | Homeobox protein PBX1 (PBX1) | ||||
Classification | Superclass | Helix-turn-helix | |||
Class | Homeo domain | ||||
Family | Homeo domain only | ||||
Subfamily | PBC | ||||
Regulation Mechanism | PBX results in a strong DNA binding affinity towards the TGACAG target site of the PLAU promoter. | [2] | |||
Evidence Score (E-score) | 1 | + | |||
1 | Electrophoretic Mobility Shift Assay | [2] | |||
UniProt ID | |||||
Sequence |
MDEQPRLMHSHAGVGMAGHPGLSQHLQDGAGGTEGEGGRKQDIGDILQQIMTITDQSLDE
AQARKHALNCHRMKPALFNVLCEIKEKTVLSIRGAQEEEPTDPQLMRLDNMLLAEGVAGP EKGGGSAAAAAAAAASGGAGSDNSVEHSDYRAKLSQIRQIYHTELEKYEQACNEFTTHVM NLLREQSRTRPISPKEIERMVSIIHRKFSSIQMQLKQSTCEAVMILRSRFLDARRKRRNF NKQATEILNEYFYSHLSNPYPSEEAKEELAKKCGITVSQVSNWFGNKRIRYKKNIGKFQE EANIYAAKTAVTATNVSAHGSQANSPSTPNSAGSSSSFNMSNSGDLFMSVQSLNGDSYQG AQVGANVQSQVDTLRHVISQTGGYSDGLAASQMYSPQGISANGGWQDATTPSSVTSPTEG PGSVHSDTSN |
||||
The Genes (Co-regulated by This TF) Grouped Based on Their Biochemical Classes | |||||
Peptidases | [+] 1 Peptidases Co-regulated By This TF | + | |||
1 | Urokinase-type plasminogen activator (PLAU) | Successful Target | Target Info | [2] | |
TF Name | Homeobox protein PBX2 (PBX2) | ||||
Classification | Superclass | Helix-turn-helix | |||
Class | Homeo domain | ||||
Family | Homeo domain only | ||||
Subfamily | PBC | ||||
Regulation Mechanism | PBX results in a strong DNA binding affinity towards the TGACAG target site of the PLAU promoter. | [2] | |||
Evidence Score (E-score) | 1 | + | |||
1 | Electrophoretic Mobility Shift Assay | [2] | |||
UniProt ID | |||||
Sequence |
MDERLLGPPPPGGGRGGLGLVSGEPGGPGEPPGGGDPGGGSGGVPGGRGKQDIGDILQQI
MTITDQSLDEAQAKKHALNCHRMKPALFSVLCEIKEKTGLSIRSSQEEEPVDPQLMRLDN MLLAEGVAGPEKGGGSAAAAAAAAASGGGVSPDNSIEHSDYRSKLAQIRHIYHSELEKYE QACNEFTTHVMNLLREQSRTRPVAPKEMERMVSIIHRKFSAIQMQLKQSTCEAVMILRSR FLDARRKRRNFSKQATEVLNEYFYSHLSNPYPSEEAKEELAKKCGITVSQVSNWFGNKRI RYKKNIGKFQEEANIYAVKTAVSVTQGGHSRTSSPTPPSSAGSGGSFNLSGSGDMFLGMP GLNGDSYSASQVESLRHSMGPGGYGDNLGGGQMYSPREMRANGSWQEAVTPSSVTSPTEG PGSVHSDTSN |
||||
The Genes (Co-regulated by This TF) Grouped Based on Their Biochemical Classes | |||||
Peptidases | [+] 1 Peptidases Co-regulated By This TF | + | |||
1 | Urokinase-type plasminogen activator (PLAU) | Successful Target | Target Info | [2] |
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Role of distinct mitogen-activated protein kinase pathways and cooperation between Ets-2, ATF-2, and Jun family members in human urokinase-type plasminogen activator gene induction by interleukin-1 and tetradecanoyl phorbol acetate. Mol Cell Biol. 1999 Sep;19(9):6240-52. | ||||
REF 2 | Prep1, a novel functional partner of Pbx proteins. EMBO J. 1998 Mar 2;17(5):1423-33. | ||||
REF 3 | Heterodimerization of c-Jun with ATF-2 and c-Fos is required for positive and negative regulation of the human urokinase enhancer. Oncogene. 1995 Jul 20;11(2):365-76. | ||||
REF 4 | Urokinase-type plasminogen activator gene regulation by polyomavirus middle-T antigen. Oncogene. 1995 Dec 7;11(11):2383-91. | ||||
REF 5 | Requirement of an upstream AP-1 motif for the constitutive and phorbol ester-inducible expression of the urokinase-type plasminogen activator recep... J Biol Chem. 1996 Sep 20;271(38):23176-84. | ||||
REF 6 | Involvement of Jun and Fos proteins in regulating transcriptional activation of the human pi class glutathione S-transferase gene in multidrug-resi... J Biol Chem. 1994 Jun 10;269(23):16397-402. | ||||
REF 7 | Negative transcriptional regulation of the interferon-gamma promoter by glucocorticoids and dominant negative mutants of c-Jun. J Biol Chem. 1995 May 26;270(21):12548-56. | ||||
REF 8 | Molecular regulation of the endothelin-1 gene by hypoxia. Contributions of hypoxia-inducible factor-1, activator protein-1, GATA-2, AND p300/CBP. J Biol Chem. 2001 Apr 20;276(16):12645-53. | ||||
REF 9 | Functional mapping of a placenta-specific upstream promoter for human gonadotropin-releasing hormone receptor gene. Endocrinology. 2001 Apr;142(4):1506-16. | ||||
REF 10 | Cyclic AMP- and phorbol ester-induced transcriptional activation are mediated by the same enhancer element in the human vasoactive intestinal peptide gene. J Biol Chem. 1991 Feb 25;266(6):3882-7. | ||||
REF 11 | Composite glucocorticoid regulation at a functionally defined negative glucocorticoid response element of the human corticotropin-releasing hormone gene. Mol Endocrinol. 1999 Oct;13(10):1629-44. | ||||
REF 12 | The Megakaryocyte/Platelet-specific enhancer of the alpha2beta1 integrin gene: two tandem AP1 sites and the mitogen-activated protein kinase signal... Blood. 1999 Mar 1;93(5):1600-11. | ||||
REF 13 | Human antioxidant-response-element-mediated regulation of type 1 NAD(P)H:quinone oxidoreductase gene expression. Effect of sulfhydryl modifying age... Eur J Biochem. 1994 Nov 15;226(1):31-9. | ||||
REF 14 | Thyroid hormone inhibits the human prolactin gene promoter by interfering with activating protein-1 and estrogen stimulations. Mol Endocrinol. 1997 Jun;11(7):986-96. | ||||
REF 15 | Expression of human p53 requires synergistic activation of transcription from the p53 promoter by AP-1, NF-kappaB and Myc/Max. Oncogene. 1999 Apr 29;18(17):2728-38. | ||||
REF 16 | The jun proto-oncogene is positively autoregulated by its product, Jun/AP-1. Cell. 1988 Dec 2;55(5):875-85. | ||||
REF 17 | Induction of bcl-2 expression by phosphorylated CREB proteins during B-cell activation and rescue from apoptosis. Mol Cell Biol. 1996 Oct;16(10):5546-56. | ||||
REF 18 | The proximal regulatory element of the interferon-gamma promoter mediates selective expression in T cells. J Biol Chem. 1996 Dec 13;271(50):31964-72. | ||||
REF 19 | Retinoblastoma gene product activates expression of the human TGF-beta 2 gene through transcription factor ATF-2. Nature. 1992 Jul 23;358(6384):331-4. | ||||
REF 20 | Differential binding of cAMP-responsive-element (CRE)-binding protein-1 and activating transcription factor-2 to a CRE-like element in the human tissue-type plasminogen activator (t-PA) gene promoter correlates with opposite regulation of t-PA by phorbol ester in HT-1080 and HeLa cells. Eur J Biochem. 1996 May 1;237(3):532-8. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.